Home Tags BA3011

Tag: BA3011

Conditionally Active Biologics (CAB)

What are Conditionally Active Biologics (CABs)?

Conditionally Active Biologics (CABs) are proteins generated using a proprietary protein discovery, evolution and expression technology developed by BioAtla, a global clinical-stage biotechnology company...

FDA Clears Investigational New Drug application for BA3011, a Novel CAB-AXL-ADC...

The U.S. Food and Drug Administration has cleared the Investigational New Drug Application (IND) for BA3011, a novel conditionally active AXL-targeted antibody-drug conjugate (CAB-AXL-ADC)...

FEATURED RESOURCES